EQNRX
Price
$20.86
Change
-$0.56 (-2.61%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

EQNRX vs RMFCX

Header iconEQNRX vs RMFCX Comparison
Open Charts EQNRX vs RMFCXBanner chart's image
MFS Equity Income R1
Price$20.86
Change-$0.56 (-2.61%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
EQNRX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EQNRX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNRX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. EQNRX (595M). RMFCX pays higher dividends than EQNRX: RMFCX (1.69) vs EQNRX (0.89). EQNRX was incepted earlier than RMFCX: EQNRX (12 years) vs RMFCX (23 years). EQNRX is a more actively managed with annual turnover of: 42.00 vs. RMFCX (25.00). EQNRX has a lower initial minimum investment than RMFCX: EQNRX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. EQNRX (11.19). RMFCX return over 5 years is better than : 40.39 vs. EQNRX (36.44).
EQNRXRMFCXEQNRX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years23 years-
Gain YTD9.56011.42384%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets595M98.7B1%
Annual Yield % from dividends0.891.6953%
Returns for 1 year11.1912.6389%
Returns for 3 years12.7214.1690%
Returns for 5 years36.4440.3990%
Returns for 10 years79.4361.84128%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc